Suppr超能文献

小鼠肥大细胞瘤细胞对拓扑异构酶II的调控

Regulation of topoisomerase II by murine mastocytoma cells.

作者信息

Collett A G, Ralph R K

机构信息

Department of Cellular and Molecular Biology, University of Auckland, New Zealand.

出版信息

Biochim Biophys Acta. 1992 Oct 20;1132(3):259-64. doi: 10.1016/0167-4781(92)90159-w.

Abstract

Nuclei from K21 murine mastocytoma cells do not form topoisomerase II-DNA adducts in response to amsacrine in the absence of a cytoplasmic factor tentatively identified as a type of casein kinase (Darkin, S.J. and Ralph, R.K. (1991) Biochim. Biophys. Acta 1088, 285-291). The stimulatory activity was present in extracts from cells grown in horse serum but not in calf serum. Activity was lost following growth arrest by serum deprivation. In contrast, topoisomerase II activity in isolated nuclei did not decline during growth arrest. These results suggest that the resistance of some non-cycling tumour cells to anti-cancer drugs may result from decreased activation of topoisomerase II.

摘要

在没有一种初步鉴定为酪蛋白激酶类型的细胞质因子的情况下,K21小鼠肥大细胞瘤细胞的细胞核不会因安吖啶而形成拓扑异构酶II - DNA加合物(Darkin, S.J.和Ralph, R.K.(1991年),《生物化学与生物物理学报》1088, 285 - 291)。刺激活性存在于在马血清中生长的细胞提取物中,而不存在于小牛血清中。血清剥夺导致生长停滞时活性丧失。相比之下,在生长停滞期间,分离细胞核中的拓扑异构酶II活性并未下降。这些结果表明,一些非循环肿瘤细胞对抗癌药物的抗性可能是由于拓扑异构酶II的激活减少所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验